{"ticker": {"uuid": "ca37fd92-2bb8-43e8-9b6e-170e255748cd", "symbol": "0775", "name": "CK Life Sciences Int'l., (Holdings) Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "CK Life Sciences\u2019 Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPS01EaGxaUzFKU2dmZzJ3TmplUDlHakxEQ3lHeF9sby1PdTVCRVpvLTdJa0xCTFAzM3NnSy1OY0VqeDlhY0FERWR1ODNNNjlPU0dtU1Y0QVk2RXNhRWFnWnVkcGxDTTBLb0tXT0t4bFZSTGlKUmV0NjBoeGtNMll3S1dqdzZpOHBQcXNuRTk3dGJmRkZwSG5HblVuQlZWd3gxSXdZbmxFSDZ0QnZaQ2UwVldpVXB5VG5ENnJZa1RJaGoxQllOMzRDc0FRRHA1SnlGU20xRURxbjRhSnJKN05YbGx0VTQ?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences\u2019 Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxOZktMTXBESzVZb1Yzc1VSRVZqRHNWQjhFSi12LTNDTzZtcWVJSElBQTlWVmVncXpQUExPR3phUGZlQXpsTF9ZWHJ5cDZwUEhfY3VNTThpQS1icHhRVlJmMDlDTVNHVWRWdE1uVjhRWTA3bEVwY3B5ZlIzT0ktVUg4YjN1em9pSWIyZmZZc3EwT2JfNmdzY0NWa3Zncm9rOTEyYnV0NUNScDFKV1lCNS1JeXNLdDlXOG9KRXd3YW5leS1FS21oME5lMXl1RDBxRXU4RHlHQ0s5M3R1dUhYOXBGRWJHVFJET191RWV0V3VJbVFoRDVIOTJEbngzNA?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences sees low geopolitical risks in a US merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORVdFOU92eTl6NTNfdDJqajVXeDFuMDVsQUpvb09TNm1aMkJLZFdObjQ5UzE3dkhJVXVYbGg2N1FDVk9OZHk5dkt2NDg4Mnp6cUdXSzZoR3hTcERZQ3gxdWoxdVlXMDNJU2laYjBYejBMMmk4UklqNWVBcEZObUZUSjE0ZWJvSDNHVjNxWjE3dFNNdlo4SkFYUTRWZHU3bjNwbXJOYzRCT2p0M3M4TnNuNFVwTTh3X2s?oc=5", "source_name": "thestandard.com.hk", "published_at": "2025-10-09T07:00:00+00:00", "published_display": "09 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPc1BBTjVzQzE3REctTkZhWmNGdUd2NmVFZ3FJVVZOVE1nTG4ta2I4eWpBWVBtSmNCT2t4eXRqYjh6ZXJfS1Z6OGtRQWJTTnVFNU1Ybk1qamdsZl9NQXRGUDd5ZlVTQ2xhRDIzdVR4akNYMzZJdEZCbFhSWTdjdk9pQ25oUzIxT3BuVjZtYlprOWlqRkYtNUdnR3pLOTMxOTl2bEh4RHdGOFczd2I0a2Y4bTdxcU5LMzRXWG5WZkVCX1VYd3FoMG1GR3hrVQ?oc=5", "source_name": "citybiz", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences' unit to merge with Nasdaq-listed TransCode Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY3dNc2RGY2VzWjZfeUk5dmp4bC13NktSWXlvZTA3UnZzSzRBOXVUTDBoVVM1RjZNVjZmWDY0dEZpOVBlNDh3dWZ0aWFJMFE4YW5RZVNvUDdTaUhoejJLZzFmaFVIZW9weVFqYkpYWUlYdzNfQTg0WXJ0YnF1Ml8zdnItQzYtcnREMzljdUxMd01MMlQ1SkhBeUxjYXNVbkJZeUxnd2Vua1pDY1pjZjUwY09BZFY3cTdyMElTZmJ3Q2VGMDNZ?oc=5", "source_name": "thestandard.com.hk", "published_at": "2025-08-10T07:00:00+00:00", "published_display": "10 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unit Of Li Ka-Shing\u2019s CK Life Sciences To Merge With Nasdaq-Listed Biotech Company In $100 Million Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOVGlwQV9XOGRZN3p5Y25pbWJmUW02TDhsSEF4SWF1UVdRWXgzSlBOa2I2aGlocW1ZbjFtOVJpcm5JXzBwNE96S3pZLW8wTlZjbGhDVFNiNGJXMnVZYzVPOE4yZDFUSjRYWW1Jb2FNUWZwRzE3eExMWmNsN3RGX2ZoWkpjazlmZ3Z1Ti1sMEpkY0NkaFNESVROYVpTUWQ3Zm9sNXdOZDkyQ2RGaXhWX2hONk9ZVWpleUVCYjF4VVZwWUdlQkRGZzlZQllONGEwdzF1QklQN3cwcExIVTByNEpxVlBIV1M1RDQ?oc=5", "source_name": "Forbes", "published_at": "2024-10-08T07:00:00+00:00", "published_display": "08 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxOMHBlN25PUDBNSVpFUzNkQzF4dEJqWm1lRE5iTl80RzhTYkpLdFpXV1lpeTJBZk1uTGRidHNEbGdIeVBBRWtCOVVvMDBneTBjNVQwaHZURW1fb19HeUliaFU1MVlZTXlnY1YyYTJJOGJTb2R5VmpKbXFhenZWRDZjZlMxenB6RkFZNDBPN2NtR1dNLXhxcXZCRW9qWjJBYkktcGx2SzB5REhHNFJWU1E4SGpfa2NmYkhYazJGR2kxRVNhNUFSU0wtc0ZET0JMVlFSdThxUUs1eDZEX0tlRzVxdW9wYjFNNVBGeDFlT1ZnSzZ2Z0YyQy16YmFLTk9ZTGoxVW1pOFIxUQ?oc=5", "source_name": "PR Newswire", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting #CKLifeSciences #CancerVaccines #R&D", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2023-11-01T07:00:00+00:00", "published_display": "01 Nov 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxQd0Q2aTBzTW4tTXFzUlpKcG9Ca2NacHhPRTJBajJEYXgtSEc2MmMwd3J2dzRraUdlSTRmVlk3QjZCZkpiUjA3UTRWRWMtTmJnaG94YWh5TDJHdnpmR1ZFZ2M5SjJCcnMyUWZ5ZUJsRERrc2d0MUtTOTZNMWJRakdQaTcycV9VM3A2ai1FUmwwMzA5YVZtMVVCSndWX1FHMWVqMnNCTVU2Vnc4X3hYaW00QlUwc3dnTjg3LTlma2VOY1VMRkFQalRHX3pHTWJXVERhbFN6N2lzM3djMWFCOXl6Z1QtQl9EanZ3UEhZd2ZPRTBNTDB5VkRuVXpSTHdGTXhGbUNRLUdqZExjVWlVRmR6c3MxUHFBWGpjVG5rT2xHRDFHRFhFamRPZGRNcw?oc=5", "source_name": "PR Newswire", "published_at": "2022-11-24T08:00:00+00:00", "published_display": "24 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks Blog: CK Life Sciences plunges; 6 companies debut in Hong Kong -- the most on one day in 2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQdHhaWTVjVnkyNzkwY1N1TXN2d0UtWDh6NHc3Q0lSdV9FeHpwMEEwcFNYc0tWbXJ5a0FCc21uX19YMm1ORGQxT1lPZ3JvQ2lkcnc3X1pvT3o5UVJxd2dyYWoxTTZ5a2I5dGo2c3RYUjNQMHNTdUhhY1BpMXU2eGZjRjNRRUYzcFpiNXd5NlhHekNZWnR4NXJjNnVEdHZzOUJPU1o0NmhOWldpQ25FTVNGZnZjMm0xdzlhdGE3UDl0Z2pDQQ?oc=5", "source_name": "South China Morning Post", "published_at": "2019-11-08T08:00:00+00:00", "published_display": "08 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CK Life Sciences\u2019 Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPS01EaGxaUzFKU2dmZzJ3TmplUDlHakxEQ3lHeF9sby1PdTVCRVpvLTdJa0xCTFAzM3NnSy1OY0VqeDlhY0FERWR1ODNNNjlPU0dtU1Y0QVk2RXNhRWFnWnVkcGxDTTBLb0tXT0t4bFZSTGlKUmV0NjBoeGtNMll3S1dqdzZpOHBQcXNuRTk3dGJmRkZwSG5HblVuQlZWd3gxSXdZbmxFSDZ0QnZaQ2UwVldpVXB5VG5ENnJZa1RJaGoxQllOMzRDc0FRRHA1SnlGU20xRURxbjRhSnJKN05YbGx0VTQ?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences\u2019 Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxOZktMTXBESzVZb1Yzc1VSRVZqRHNWQjhFSi12LTNDTzZtcWVJSElBQTlWVmVncXpQUExPR3phUGZlQXpsTF9ZWHJ5cDZwUEhfY3VNTThpQS1icHhRVlJmMDlDTVNHVWRWdE1uVjhRWTA3bEVwY3B5ZlIzT0ktVUg4YjN1em9pSWIyZmZZc3EwT2JfNmdzY0NWa3Zncm9rOTEyYnV0NUNScDFKV1lCNS1JeXNLdDlXOG9KRXd3YW5leS1FS21oME5lMXl1RDBxRXU4RHlHQ0s5M3R1dUhYOXBGRWJHVFJET191RWV0V3VJbVFoRDVIOTJEbngzNA?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences sees low geopolitical risks in a US merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORVdFOU92eTl6NTNfdDJqajVXeDFuMDVsQUpvb09TNm1aMkJLZFdObjQ5UzE3dkhJVXVYbGg2N1FDVk9OZHk5dkt2NDg4Mnp6cUdXSzZoR3hTcERZQ3gxdWoxdVlXMDNJU2laYjBYejBMMmk4UklqNWVBcEZObUZUSjE0ZWJvSDNHVjNxWjE3dFNNdlo4SkFYUTRWZHU3bjNwbXJOYzRCT2p0M3M4TnNuNFVwTTh3X2s?oc=5", "source_name": "thestandard.com.hk", "published_at": "2025-10-09T07:00:00+00:00", "published_display": "09 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPc1BBTjVzQzE3REctTkZhWmNGdUd2NmVFZ3FJVVZOVE1nTG4ta2I4eWpBWVBtSmNCT2t4eXRqYjh6ZXJfS1Z6OGtRQWJTTnVFNU1Ybk1qamdsZl9NQXRGUDd5ZlVTQ2xhRDIzdVR4akNYMzZJdEZCbFhSWTdjdk9pQ25oUzIxT3BuVjZtYlprOWlqRkYtNUdnR3pLOTMxOTl2bEh4RHdGOFczd2I0a2Y4bTdxcU5LMzRXWG5WZkVCX1VYd3FoMG1GR3hrVQ?oc=5", "source_name": "citybiz", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences' unit to merge with Nasdaq-listed TransCode Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY3dNc2RGY2VzWjZfeUk5dmp4bC13NktSWXlvZTA3UnZzSzRBOXVUTDBoVVM1RjZNVjZmWDY0dEZpOVBlNDh3dWZ0aWFJMFE4YW5RZVNvUDdTaUhoejJLZzFmaFVIZW9weVFqYkpYWUlYdzNfQTg0WXJ0YnF1Ml8zdnItQzYtcnREMzljdUxMd01MMlQ1SkhBeUxjYXNVbkJZeUxnd2Vua1pDY1pjZjUwY09BZFY3cTdyMElTZmJ3Q2VGMDNZ?oc=5", "source_name": "thestandard.com.hk", "published_at": "2025-08-10T07:00:00+00:00", "published_display": "10 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unit Of Li Ka-Shing\u2019s CK Life Sciences To Merge With Nasdaq-Listed Biotech Company In $100 Million Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOVGlwQV9XOGRZN3p5Y25pbWJmUW02TDhsSEF4SWF1UVdRWXgzSlBOa2I2aGlocW1ZbjFtOVJpcm5JXzBwNE96S3pZLW8wTlZjbGhDVFNiNGJXMnVZYzVPOE4yZDFUSjRYWW1Jb2FNUWZwRzE3eExMWmNsN3RGX2ZoWkpjazlmZ3Z1Ti1sMEpkY0NkaFNESVROYVpTUWQ3Zm9sNXdOZDkyQ2RGaXhWX2hONk9ZVWpleUVCYjF4VVZwWUdlQkRGZzlZQllONGEwdzF1QklQN3cwcExIVTByNEpxVlBIV1M1RDQ?oc=5", "source_name": "Forbes", "published_at": "2024-10-08T07:00:00+00:00", "published_display": "08 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxOMHBlN25PUDBNSVpFUzNkQzF4dEJqWm1lRE5iTl80RzhTYkpLdFpXV1lpeTJBZk1uTGRidHNEbGdIeVBBRWtCOVVvMDBneTBjNVQwaHZURW1fb19HeUliaFU1MVlZTXlnY1YyYTJJOGJTb2R5VmpKbXFhenZWRDZjZlMxenB6RkFZNDBPN2NtR1dNLXhxcXZCRW9qWjJBYkktcGx2SzB5REhHNFJWU1E4SGpfa2NmYkhYazJGR2kxRVNhNUFSU0wtc0ZET0JMVlFSdThxUUs1eDZEX0tlRzVxdW9wYjFNNVBGeDFlT1ZnSzZ2Z0YyQy16YmFLTk9ZTGoxVW1pOFIxUQ?oc=5", "source_name": "PR Newswire", "published_at": "2023-11-06T08:00:00+00:00", "published_display": "06 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting #CKLifeSciences #CancerVaccines #R&D", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Media OutReach Newswire", "published_at": "2023-11-01T07:00:00+00:00", "published_display": "01 Nov 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxQd0Q2aTBzTW4tTXFzUlpKcG9Ca2NacHhPRTJBajJEYXgtSEc2MmMwd3J2dzRraUdlSTRmVlk3QjZCZkpiUjA3UTRWRWMtTmJnaG94YWh5TDJHdnpmR1ZFZ2M5SjJCcnMyUWZ5ZUJsRERrc2d0MUtTOTZNMWJRakdQaTcycV9VM3A2ai1FUmwwMzA5YVZtMVVCSndWX1FHMWVqMnNCTVU2Vnc4X3hYaW00QlUwc3dnTjg3LTlma2VOY1VMRkFQalRHX3pHTWJXVERhbFN6N2lzM3djMWFCOXl6Z1QtQl9EanZ3UEhZd2ZPRTBNTDB5VkRuVXpSTHdGTXhGbUNRLUdqZExjVWlVRmR6c3MxUHFBWGpjVG5rT2xHRDFHRFhFamRPZGRNcw?oc=5", "source_name": "PR Newswire", "published_at": "2022-11-24T08:00:00+00:00", "published_display": "24 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks Blog: CK Life Sciences plunges; 6 companies debut in Hong Kong -- the most on one day in 2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQdHhaWTVjVnkyNzkwY1N1TXN2d0UtWDh6NHc3Q0lSdV9FeHpwMEEwcFNYc0tWbXJ5a0FCc21uX19YMm1ORGQxT1lPZ3JvQ2lkcnc3X1pvT3o5UVJxd2dyYWoxTTZ5a2I5dGo2c3RYUjNQMHNTdUhhY1BpMXU2eGZjRjNRRUYzcFpiNXd5NlhHekNZWnR4NXJjNnVEdHZzOUJPU1o0NmhOWldpQ25FTVNGZnZjMm0xdzlhdGE3UDl0Z2pDQQ?oc=5", "source_name": "South China Morning Post", "published_at": "2019-11-08T08:00:00+00:00", "published_display": "08 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 12, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 11, "score": 49, "total": 12, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.59, "latest_week": "2026-07-10", "one_week_move": -1.7, "four_week_move": -13.2, "twelve_week_move": -19.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.00016, "market_dynamics_buy_signal": false, "relative_strength": -23.758482, "fair_value_gap": -7.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 35.5615, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.7% over one week, -13.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Media OutReach Newswire", "count": 3}, {"label": "PR Newswire", "count": 3}, {"label": "thestandard.com.hk", "count": 2}, {"label": "The Manila Times", "count": 1}, {"label": "citybiz", "count": 1}, {"label": "Forbes", "count": 1}, {"label": "South China Morning Post", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 12}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Deals and strategy", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "12", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.7% over one week, -13.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CK Life Sciences\u2019 Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer"}], "updated_at": "2026-07-18T00:56:43.688280+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}